[1]
“Pharmacovigilance challenges of COVID-19 vaccine safety monitoring during the pandemic - a narrative review”, Prospect. Pharm. Sci., vol. 24, no. 2, pp. 149–160, June 2026, doi: 10.56782/pps.739.